Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cybin Inc
(NY:
CYBN
)
0.3500
+0.0040 (+1.16%)
Official Closing Price
Updated: 8:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cybin Inc
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Cybin to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
August 25, 2022
From
Cybin Inc.
Via
Business Wire
How Meditation, Psychedelics Can Boost Healing
August 24, 2022
Via
Investor Brand Network
FT-104: Field Trip’s Latest Psychedelic Drug Candidate
August 22, 2022
Via
Investor Brand Network
Study Suggests LSD May Boost Learning, Memory by Enhancing Neural Plasticity
August 18, 2022
Via
Investor Brand Network
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Partner Receive Required Schedule I License from DEA for First-in-Human Clinical Trial
August 17, 2022
Via
Investor Brand Network
Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical Trial
August 17, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Results of Annual Meeting of Shareholders
August 16, 2022
Via
Investor Brand Network
Cybin Announces Results of Shareholders’ Meeting
August 15, 2022
From
Cybin Inc.
Via
Business Wire
Psilocybin Lawsuit Filed in Canada May Boost Global Psychedelics Reform Efforts
August 12, 2022
Via
Investor Brand Network
Topics
Lawsuit
Exposures
Financial
Legal
Brain Fingerprinting Adolescents Could Predict Future Mental-Health Issues
August 10, 2022
Via
Investor Brand Network
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
August 10, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study...
Via
FinancialNewsMedia
Topics
Supply Chain
Exposures
Supply Chain
BioMedNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Unveils Equity Program, Releases Q1 Financial Report
August 09, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
CORRECTING and REPLACING Cybin Announces Up to USD$35 Million At-The-Market Equity Program
August 08, 2022
From
Cybin Inc.
Via
Business Wire
Cybin Inc. Reports First Quarter Financial Results and Recent Business Highlights
August 08, 2022
From
Cybin Inc.
Via
Business Wire
Toronto Firm Receives First Federal Government Funding to Study Psilocybin
August 08, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program
August 03, 2022
Via
Investor Brand Network
New Poll Finds Most Americans Support Research on Psychedelics for Military Members
August 03, 2022
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Study Finds That Difficulty Sleeping, Financial Stressors Increase Mental Health Risk in University Students
August 02, 2022
Via
Investor Brand Network
Research Finds Psychedelics May Open Door to Self-Actualization
July 29, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO to Participate in Upcoming Canaccord Genuity Growth Conference
July 28, 2022
Via
Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Cleared for Historic Study, Begins Enrolling Participants
July 28, 2022
Via
Investor Brand Network
Cybin to Present at the Canaccord Genuity 42nd Annual Growth Conference
July 28, 2022
From
Cybin Inc.
Via
Business Wire
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders
July 27, 2022
Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam...
Via
FinancialNewsMedia
Topics
Law Enforcement
Exposures
Legal
Research Suggests How Individuals Can Control Unwanted Thoughts
July 26, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Scheduled Annual Shareholder Meeting
July 26, 2022
Via
Investor Brand Network
Cybin Announces Date of Annual Meeting of Shareholders
July 25, 2022
From
Cybin Inc.
Via
Business Wire
What You Should Know, Do Before Investing in Psychedelics Stocks
July 25, 2022
Via
Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Completes Acquisition of Largest-Ever DMT Study
July 25, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Unlocking ‘New Frontiers of Discovery’ with Kernel Flow
July 20, 2022
Via
Investor Brand Network
House Approves Amendments on Psychedelic Therapy in Defense Spending Measure
July 20, 2022
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.